Clinical trial

STAR Cape+BKM120 MBC With Brain Met

NCT02000882

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-05-29

PhasePHASE2

Study timeline

Study start (actual)2014-05-29Date precision: day

Registry last updated2022-02-07

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Brain Metastasesunresolved

Breast Cancerverified · MONDO: breast cancer

Metastatic Breast Cancerunresolved

Interventions

BKM120DRUG

capecitabineDRUG · verified · RxNorm: capecitabine

TrastuzumabDRUG · verified · RxNorm: trastuzumab

Sponsors & collaborators

US Oncology Researchlead sponsor

Novartis Pharmaceuticalscollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02000882 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.